NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered BPC-157 from Nexaph? Mail in a sample (US only) and let us test it for free.

Test my supply
65%
Finnrick rating
#1 of 110 BPC-157 vendors
13 of 17 classifiable tests passed
natural 76% · customers 4.7★ (16)
methodology · Accuracy focus
Finnrick analysis · BPC-157

Across 253 Finnrick lab tests, Nexaph’s overall pass rate is 60%, with GHK-Cu stronger and CJC-1295 the clearest weak signal. The full report maps a fragmented corporate/operator trail, sister-brand infrastructure, cloned COA pathways, China-origin supply claims, payment quirks and a documented Tirzepatide T30 sterility incident.

methodology →
vendor intelligence report
Vendor Intelligence Report: Nexaph

Corporate records, RDAP data and site emails trace Nexaph through a fragmented operator identity rather than a clean public counterparty. The report maps sister-brand infrastructure, COA-cloning pathways and a certification/payment layer that changes buyer recourse.

31 pages8 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$0.81
73%
56
2
BPC-157selected
$1.28
65%
17
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%10 Jul 2025: 46%17 Jul 2025: 43%6 Aug 2025: 40%31 Aug 2025: 44%9 Sept 2025: 48%21 Oct 2025: 45%15 Jan 2026: 49%2 Feb 2026: 52%4 Mar 2026: 50%6 Mar 2026: 53%18 Mar 2026: 56%23 Apr 2026: 59%28 Apr 2026: 61%28 Apr 2026: 63%12 Jun 2026: 66%3 Sept 2026: current 65%46%49%65%Jul 25Sep 26
Showing BPC-157 tests only
Free peptide testing

Ordered BPC-157 from Nexaph? Mail in a sample (US only) and let us test it for free.

Test my supply
Nexaph BPC-157 test history
COA-backed lab tests
1-10 of 17

About Nexaph test results from Finnrick

Nexaph is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 267 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Nexaph peptides in this dataset are Tirzepatide (56 tests) and BPC-157 (17 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered BPC-157 from Nexaph? Mail in a sample (US only) and let us test it for free.

Test my supply